ARKR vs REGN · rev $118.2M vs P/E 14, rev $4.29B
Ark Restaurants Corp (ARKR) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Ark Restaurants Corp (ARKR) is a restaurants company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported ARKR revenue for 2026-06-27 was $118.2M. Net income was -$1.3M. Revenue was up 52.9% from 2026-03-28 to 2026-06-27. ARKR currently screens at market cap $22.5M.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
ARKR currently screens at market cap $22.5M. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the ARKR and REGN stock pages for the full models.
Not investment advice.